Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
The CagriSema combination produces 15-25% body weight loss (superior to semaglutide's 10-15% alone) by targeting multiple weight regulation pathways simultaneously
This is an alarming sign for the GLP-1 industry as the impact of tariffs looms in an already uncertain market, affecting other areas of consumer spending, such as travel, for example
Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 Trials
Boosting energy during caloric restriction
Potential Mood Regulation: Research suggests Vitamin D may be linked to mood regulation, with some studies indicating a connection between deficiency and symptoms of depression